R&I | Jotup

InterDigital and Concordia University Announce Research Collaboration on AI-enabled Immersive Media Delivery over 5G Networks

Retrieved on:

Lunedì, Aprile 15, 2024

Specifically, the collaboration supports research and innovation (R&I) into novel media delivery paradigms, approaches, prototype tools, and evaluation results.

Key Points:

Specifically, the collaboration supports research and innovation (R&I) into novel media delivery paradigms, approaches, prototype tools, and evaluation results.
The research will also explore the development of systems that support the efficient delivery of high-quality, six degrees of freedom (6DoF), volumetric immersive media content over 5G networks.
Together, InterDigital and Concordia University’s research collaboration aims to design an end-to-end immersive media transport system, addressing media packaging, media ingesting, media delivery, and media consumption, that abides by media coding standards set by IETF, MPEG, and 3GPP.
“We are excited to announce this partnership with Concordia University to explore and create systems and tools to support the exciting intersection between AI and immersive media delivery protocols,” said Gaëlle Martin-Cocher, Senior Director at InterDigital.

Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025

Retrieved on:

Mercoledì, Marzo 27, 2024

Extended financial visibility secured until Q4 2025 through a revised credit facility provided by the major shareholder Institut Mérieux.

Key Points:

Extended financial visibility secured until Q4 2025 through a revised credit facility provided by the major shareholder Institut Mérieux.
“During 2023 Transgene continued to make significant progress, delivering compelling data that confirm the value of our approach to treating cancer using our novel immunotherapies” commented Dr. Alessandro Riva, MD, Chairman and CEO of Transgene.
As announced on May 5, 2023, AstraZeneca terminated its oncolytic virus research and development collaboration with Transgene following a strategic review of its pipeline.
In 2024, Transgene expects to communicate progress and significant results and readout on all of its clinical stage assets.

MHI Concludes Nissay Positive Impact Finance Agreement

Retrieved on:

Venerdì, Febbraio 9, 2024

TOKYO, Feb 9, 2024 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) has concluded a Nissay Positive Impact Finance (Note1) agreement with Nippon Life Insurance Company (Nippon Life) (contract amount: JPY 6.0 billion yen).

Key Points:

TOKYO, Feb 9, 2024 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) has concluded a Nissay Positive Impact Finance (Note1) agreement with Nippon Life Insurance Company (Nippon Life) (contract amount: JPY 6.0 billion yen).
Positive Impact Finance (PIF) is a loan intended to provide continuous support for corporate activities while comprehensively analyzing and evaluating the impacts (both positive and negative) that those activities have on the environment, society, and the economy, based on the Principles for Positive Impact Finance and implementation guidelines formulated by the United Nations Environment Programme Finance Initiative (UNEP FI).
The Principles for Positive Impact Finance, formulated by the UNEP FI in January 2017, is a financial framework for achieving SDGs.
(1) Nissay Positive Impact Finance is ESG-themed investment provided by Nippon Life.

COSMAX Established OTC Lab…'Targeting the $2.6 Billion U.S. sun care market'

Retrieved on:

Venerdì, Gennaio 26, 2024

Research, ODM, Multimedia, U.S. FDA, Oil, R&I, Cosmetics, OTC, Food, FDA, Certification

SEONGNAM, South Korea, Jan. 26, 2024 /PRNewswire/ -- COSMAX, a global cosmetics research, development, and manufacturing (ODM) company, has established a specialized organization for over-the-counter (OTC) sunscreen products. The company aims to enhance its expertise in the sun care field in response to the growing demands of its clients who wish to enter the U.S. cosmetics market with sunscreen products.

Key Points:

COSMAX has announced the establishment of the 'OTC Lab' within its R&I (Research & Innovation) Center in South Korea.
Having obtained approval from the U.S. FDA, COSMAX produces OTC sun care products at its facilities in South Korea (Hwaseong plant) and the U.S. (New Jersey plant).
Chun-ho Park, Vice President of COSMAX R&I Center, stated, "In response to the increasing demand from Korean and global clients to enter the U.S. sun care market, we have established OTC Lab."
The OTC sun care market in the U.S. is approximately $2.6 billion, accounting for over 20% of the total market share.

Eisai and Mizuho Sign Sustainability-Linked Loan Agreement

Retrieved on:

Giovedì, Dicembre 14, 2023

TOKYO, Dec 14, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Mizuho Bank, Ltd. announced today that the companies have signed a sustainability-linked syndicated loan agreement, which comes into effect today.

Key Points:

TOKYO, Dec 14, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Mizuho Bank, Ltd. announced today that the companies have signed a sustainability-linked syndicated loan agreement, which comes into effect today.
Under the concept of human health care (hhc), Eisai aims to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities.
With the funds raised through this agreement, Eisai will promote the creation of social impact through the elimination of diseases of poverty (neglected tropical diseases, malaria, tuberculosis, etc.
This agreement has undergone a third-party review* by Rating and Investment Information, Inc. (R&I) regarding its compliance with the Sustainability-Linked Loan Principles issued by the Loan Market Association and other organizations, as well as the Green Loan and Sustainability-Linked Loan Guidelines issued by Japan's Ministry of the Environment.

Mitsubishi Electric to Issue Green Bonds for First Time

Retrieved on:

Venerdì, Novembre 10, 2023

Other Manufacturing, Environment, Technology, Semiconductor, Professional Services, Manufacturing, Green Technology, Hardware, Other Professional Services, Green bond, Silicon carbide, International Capital Market Association, R&I, Mitsubishi Electric, R, Israel Electric Corporation, ICMA, Security (finance)

Mitsubishi Electric Corporation (TOKYO:6503) announced today that it will issue green bonds for the first time to raise funds for the construction of a silicon carbide (SiC) power semiconductor plant and the enhancement of related production facilities that handle products capable of contributing to decarbonization.

Key Points:

Mitsubishi Electric Corporation (TOKYO:6503) announced today that it will issue green bonds for the first time to raise funds for the construction of a silicon carbide (SiC) power semiconductor plant and the enhancement of related production facilities that handle products capable of contributing to decarbonization.
Green bonds are any type of debt instrument issued by a corporation or municipality for the exclusive purpose of financing or refinancing green projects domestically or internationally.
In preparation for the issuance, Mitsubishi Electric has formulated a Green Bond Framework that specifies its policies regarding the use of proceeds, the process for project evaluation and selection, the management of proceeds, and reporting, as defined in the Green Bond Principles 2021 issued by the International Capital Market Association (ICMA) and the Green Bond Guidelines 2022 issued by Japan’s Ministry of the Environment.
Mitsubishi Electric has also submitted an amended shelf registration statement for the issuance of the bonds to the Director-General of the Kanto Local Finance Bureau.

InterDigital’s Alec Brusilovsky Elected Vice Chair of the ETSI Industry Specification Group on Securing AI

Retrieved on:

Giovedì, Giugno 1, 2023

SBS, European Telecommunications Satellite Organization, InterDigital, Alec, Rapporteur, Research, SAI, Privacy, R&I, Artificial intelligence, IDCC, ETSI, Medical device, Huawei, AI

WILMINGTON, Del., June 01, 2023 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, announced the election of R&I Principal Engineer Alec Brusilovsky to Vice Chair the ETSI Industry Specification Group on Securing Artificial Intelligence (ETSI ISG SAI).

Key Points:

WILMINGTON, Del., June 01, 2023 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, announced the election of R&I Principal Engineer Alec Brusilovsky to Vice Chair the ETSI Industry Specification Group on Securing Artificial Intelligence (ETSI ISG SAI).
The ETSI ISG SAI explores three key areas, including the use of AI to enhance conventional security, how to mitigate against AI-generated attacks, and ways to secure AI from attack.
Amidst the growing interest and commercial utilization of AI/ML tools, the ETSI ISG SAI works to create standards to preserve and improve the security of AI.
Alec will begin his two-year term immediately, serving alongside vice-chairs from Huawei and SBS, with Cadzow Communications chairing the industry specification group.

Solvay Announces Strategic Collaboration With Ginkgo Bioworks And Expands Its R&I Footprint In The United States

Retrieved on:

Martedì, Aprile 4, 2023

BRUSSELS and BOSTON, April 4, 2023 /PRNewswire/ -- Solvay, a leading science and materials company whose technologies bring benefits to many aspects of daily life, today announced a strategic collaboration with Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity. Through this multi-year strategic collaboration agreement, Solvay will join forces with Ginkgo to unlock the power of synthetic biology as an enabler of more sustainable chemicals and materials, contributing to the transition towards more environmentally-friendly solutions. This alliance will start by focusing on new sustainable biopolymers, specialties which could tangibly impact a breadth of markets, from home and personal care to agriculture and food.

Key Points:

The investment will accelerate the development of new sustainable biopolymers, strengthening Solvay's position in biotechnology in this important growth platform.
Through this multi-year strategic collaboration agreement, Solvay will join forces with Ginkgo to unlock the power of synthetic biology as an enabler of more sustainable chemicals and materials, contributing to the transition towards more environmentally-friendly solutions.
As part of this partnership, Solvay will also acquire a Ginkgo (formerly Zymergen) laboratory in Cambridge, Massachusetts.
This growth platform complements the company's activities in three other key areas: battery materials, green hydrogen and thermoplastic composites.

Ventas Reports 2022 Fourth Quarter and Full Year Results and Provides 2023 Outlook

Retrieved on:

Giovedì, Febbraio 9, 2023

Consistent with its strategic capital allocation priorities, Ventas closed or committed $1.2 billion in total investments in 2022:

Key Points:

Consistent with its strategic capital allocation priorities, Ventas closed or committed $1.2 billion in total investments in 2022:
Notably, Ventas continued expanding its life science, R&I footprint, as evidenced by $0.7 billion in closed or committed projects in 2022.
Consistent with the Company’s pre-pandemic practice, the Company is reintroducing full year guidance for 2023.
The Company’s 2023 guidance contains forward-looking statements and is based on a number of assumptions; actual results may differ materially.
Ventas expects to report 2023 per share attributable net income to common stockholders, Nareit FFO and Normalized FFO within the following ranges:

Cambridge GaN Devices and IFP Energies nouvelles Sign Automotive Inverter Development Deal

Retrieved on:

Martedì, Dicembre 13, 2022

Cambridge GaN Devices (CGD) , the fabless, clean-tech semiconductor company that develops a range of energy-efficient GaN-based power devices to make greener electronics possible, has signed an agreement with IFP Energies nouvelles (IFPEN) , a major French public research and training organization in the fields of energy, transport and the environment, to develop an innovative automotive inverter using advanced GaN devices.

Key Points:

Cambridge GaN Devices (CGD) , the fabless, clean-tech semiconductor company that develops a range of energy-efficient GaN-based power devices to make greener electronics possible, has signed an agreement with IFP Energies nouvelles (IFPEN) , a major French public research and training organization in the fields of energy, transport and the environment, to develop an innovative automotive inverter using advanced GaN devices.
Therefore we are particularly excited that IFPEN has chosen CGDs ICeGaN GaN HEMTs in this new automotive inverter design.
Cambridge GaN Devices (CGD) is a fabless semiconductor company spun-out by Professor Florin Udrea and Dr Giorgia Longobardi from Cambridge University in 2016 to exploit a revolutionary technology in power devices.
IFP Energies nouvelles (IFPEN) is a major research and training player in the fields of energy, transport and the environment.